Breast Cancer Research and Treatment

, Volume 11, Issue 1, pp 59–66 | Cite as

Weight gain in women with localized breast cancer — a descriptive study

  • Pamela J. Goodwin
  • Tony Panzarella
  • Norman F. Boyd


A retrospective study was undertaken of weight gain during the first year after diagnosis of breast cancer in three groups of women with localized disease. Group I consisted of 307 women with clinical or pathological node-negative breast cancer and Group II of 139 women with clinical or pathological node-positive breast cancer. Neither of these groups received systemic adjuvant therapy. Group III consisted of 191 women with pathological node-positive breast cancer who received adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) (Group IIIA) or CMF plus prednisone (7.5 mg per day) and ovarian ablation (Group IIIB).

In the absence of systemic therapy, weight gain was greater in those with involved nodes than in those with uninvolved nodes (p = 0.001). When women with involved nodes were studied, those who received prednisone and ovarian ablation in addition to CMF gained more weight than those who received CMF alone (p<0.0001). The use of CMF alone did not significantly affect weight gain. Neither initial weight nor weight gain after diagnosis affected prognosis.

It was concluded that the observed weight gain was not due to the use of adjuvant CMF and did not affect prognosis. Further investigation was recommended to replicate the above findings and to determine the cause of weight gain after diagnosis in women with localized breast cancer.

Key words

adjuvant therapy prognosis weight gain 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Foltz AT: Weight gain among stage II breast cancer patients: A study of five factors. Oncology Nursing Forum 12: 21–26, 1985Google Scholar
  2. 2.
    Heasman KZ, Sutherland HJ, Campbell JA, Elhakim T, Boyd NF: Weight gain during adjuvant therapy for breast cancer. Breast Cancer Res Treat 5: 195–200, 1985PubMedGoogle Scholar
  3. 3.
    Knobf MK, Mullen JC, Xistris D, Moritz DA: Weight gain in women with breast cancer receiving adjuvant chemotherapy. Oncology Nursing Forum 10: 28–33, 1983Google Scholar
  4. 4.
    Hernandez BM, Bonomi P, Hoeltgen T, Roseman DL, Slayton RE, Wolter J, Foltz A: Weight gain in the adjuvant chemotherapy of breast cancer. Proc ASCO 2: C-422, 1983 (Abstr)Google Scholar
  5. 5.
    Subramanian VP, Raich PC, Walker BK: Weight gain in breast cancer patients undergoing chemotherapy. Breast Cancer Res Treat 1: 170, 1981 (Abstr)Google Scholar
  6. 6.
    DeConti R: Weight gain in the adjuvant chemotherapy of breast cancer. Proc ASCO: C-143, 1981 (Abstr)Google Scholar
  7. 7.
    Dixon J, Moritz DA, Baker FL: Breast cancer and weight gain: An unexpected finding. Oncology Nursing Forum 5:5–7, 1978Google Scholar
  8. 8.
    Donegan WL, Hartz AJ, Rimm AA: The association of body weight and recurrent cancer of the breast. Cancer 41: 1590–1594, 1978PubMedGoogle Scholar
  9. 9.
    Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ, Meakin JW: Body weight and prognosis in breast cancer. J Natl Cancer Inst 67: 785–789, 1981PubMedGoogle Scholar
  10. 10.
    Tartter PE, Papatestas AE, Iannovitch J, Mulvihill MN, Lesnick G, Aufses AH: Cholesterol and obesity as prognostic factors in breast cancer. Cancer 47: 2222–2227, 1981PubMedGoogle Scholar
  11. 11.
    Zumoff B, Gorzynski JG, Katz JL, Weiner H, Levin J, Holand J, Fukushima DK: Nonobesity at the time of mastectomy is highly predictive of 10 year disease free survival in women with breast cancer. Anticancer Res 2: 59–62, 1982PubMedGoogle Scholar
  12. 12.
    Ederlein T, Simon R, Fisher S, Lippman ME: Height, weight, and risk of breast cancer relapse. Breast Cancer Res Treat 5: 81–86, 1985PubMedGoogle Scholar
  13. 13.
    Abe R, Kumagai N, Kimura M, Hirosaki A, Nakamura T: Biological characteristics of breast cancer in obesity. Tohoku J Exp Med 120: 351–359, 1976PubMedGoogle Scholar
  14. 14.
    Benn R: Some mathematical properties of weight-forheight indices used as measures of adiposity. Br J Prev Soc Med 25: 42–50, 1971PubMedGoogle Scholar
  15. 15.
    Cox R: Regression models and life tables. J R Stat Soc (Series B) 34: 187–220, 1972Google Scholar
  16. 16.
    Rowland-Payne CME, Abbott M, Jones JM, Powles TJ, Coombes RC: Weight loss during therapy for advanced breast cancer. Clinical Oncology 8: 33–38, 1982PubMedGoogle Scholar
  17. 17.
    Harris JR, Hellman S, Cannelos GP, Fisher B: Cancer of the Breast. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer. Principles and Practice of Oncology, Second Edition. JB Lippincott Co, Philadelphia, 1985, pp. 1125Google Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • Pamela J. Goodwin
    • 1
    • 3
  • Tony Panzarella
    • 2
  • Norman F. Boyd
    • 1
  1. 1.Department of MedicineOntario Cancer InstituteCanada
  2. 2.Department of BiostatisticsOntario Cancer InstituteCanada
  3. 3.Research Fellow of the National Cancer Institute of CanadaCanada

Personalised recommendations